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Abstract. Intracranial vascular malformations (IVMs)
are responsible for 49% of spontaneous intraparen-
chymal brain haemorrhage in patients under 40 years
of age. IVMs may cause recurrent intracranial bleeds,
focal neurological deficits, seizures and chronic disabil-
ity. The aim was to study the incidence of arterio-venous
malformations (AVMs) and cerebral cavernous malform-
ations (CCMs) in the Maltese population, assess mode
of presentation, patterns of interventions, outcomes and
follow-up of the lesions. A word search through the ra-
diology information system was carried out, identifying
cases of IVMs between 2008 and 2016 at Mater Dei Hos-
pital. Brain or dural AVM, carotid-cavernous fistulae
and CCM were included in the study. A participant was
identified as the “incident” case at the time of the first
diagnostic image. Interventions, follow-ups and com-
plications were noted. 47 patients had AVM and 35 had
CCM. The majority of patients with AVM presented
with headaches. MRI was the prevalent imaging mod-
ality used at diagnosis. 42.6% of patients received ra-
diosurgery. Haemorrhage was the commonest complic-
ation. In the CCM group, seizures and focal signs were
common presenting symptoms. 65.7% of patients with
a CCM were followed-up with further imaging within
one year of diagnosis. The majority of patients received
no intervention. IVMs may cause significant morbid-
ity in patients and timely recognition is essential. The
risk of haemorrhage in patients with AVMs is 1–4% per
annum and this risk directs management. Presently,
decisions regarding CCMs are made on a case-by-case
basis. There is a need for guidelines, to help direct clini-
cians on the evidence-based management of IVMs.
Keywords: intracranial vascular malformations, ar-
teriovenous malformation, cavernoma, cavernous mal-
formation
1 Introduction
Intracranial vascular malformations (ICM) are abnor-
malities in the cerebral arterial and venous systems and
can incorporate a vast number of vascular lesions that
have differing structure, haemodynamics and prognosis.
While some might be life-threatening, such as arteri-
ovenous malformations or a vein of Galean aneurysmal
malformation, others might be found incidentally and
might remain asymptomatic throughout a patient’s life-
time. ICMs are sub-classified into those malformations
that occur in the presence of shunting such as arterio-
venous malformations (AVMs) and arteriovenous fistula
(including dural arteriovenous fistula, dural sinus mal-
formation and vein of Galean aneurysmal malformation)
and those which occur in the absence of shunting such
as cavernoma and venous malformations.
These ICMs are responsible for over a third of spon-
taneous intraparenchymal brain haemorrhage in pa-
tients under 40 years of age (Ru´ız-Sandoval JL & Barin-
agarrementeria, 1999) hence, making them the leading
cause of haemorrhage in this age group. Lesions might
be found incidentally or the patient might present with
persisting headaches, global or focal seizures, upper mo-
tor neurone signs and rarely death due to a signific-
ant intraparenchymal bleed. They may be the cause
for recurrent intracranial bleed, focal neurological de-
ficits such as hemiplegia, seizures and chronic disabil-
ity. While therapeutic interventions such as radiosur-
gery, surgical excision and embolization can be useful in
alleviating symptoms in a number of patients, there re-
mains uncertainty on the prognosis such malformations
carry in certain individuals and on the clinical course of
untreated IVMs.
The aim of the study was to study the incidence of
AVMs and cavernomas in the Maltese population, assess
their mode of presentation and outcomes. Patterns of
interventions and modes of follow-up of lesions were also
noted. Outcomes of patients who did not receive inter-
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ventional treatment were also monitored shedding light
on the beneficial and adverse effects of the used inter-
ventions. Moreover, there haven’t been any publications
with regards to the incidence of these malformations in
the Maltese islands and thus this study is the first pub-
lished population based study shedding light into the
presentation and outcomes of these patients.
2 Materials and Methods
A word search through the radiology information system
was carried out, identifying cases of intracranial vascular
malformations between January 2008 and October 2016
which were diagnosed at Mater Dei Hospital. Search cri-
teria included cavernoma, cavernous malformation, AV1
fistula, arteriovenous +/− malformations, AVM/s, AV
fistula and arteriovenous fistula. Fistulas or AVMs oc-
curring elsewhere in the body including renal, bladder,
trunk or abdomen were excluded from the study. Pa-
tients included in the study were aged 14 years or over at
the time of diagnosis. Any patient with a brain AVM,
dural arteriovenous AVM, including carotid-cavernous
fistulae and cavernous malformation with or without a
venous malformation diagnosed between 2008 and 2016
were included in the study. Vein of Galean aneurysmal
malformations were included in the study yet all other
aneurysms were excluded. A participant was identified
as the “incident” case at the time of first diagnostic
image being it CT2 (including CT Angiogram), MR3
(including MR angiogram) or catheter angiogram. Pat-
terns of intervention were then monitored including both
observational and surgical treatment. Any complica-
tions noted at the time of diagnosis or subsequently were
then documented and analysed.
3 Results
82 patients were included in the study of which 47 had
AVMs and 35 had a cavernoma as shown in Table 1.
The incidence of newly diagnosed AVM in the Maltese
Islands between 2008 and 2016 was 0.01% whilst that of
cavernomas was 0.008%.
The mode of presentation of both AVM and cav-
ernoma are as shown in Fig. 1. The commonest present-
ation with regards to AVMs was with headaches (28%),
followed by neurological deficit (21.3%) and seizures
(17%). 26% of AVMs were diagnosed incidentally in
comparison to 43% of cavernomas. Symptomatic cav-
ernomas presented mostly with seizures (20%) and neur-
ological deficits (20%) with only 17% presenting with
headaches.
MRIs were the commonest imaging modality used at
the time of diagnosis of an AVM (47.8%) followed by MR
Angiography (23.4%) and CT Scans (including CT An-
1AV – arteriovenous
2CT – computed tomography scan
3MR – magnetic resonance
Figure 1: Mode of presentation of ICM. Headaches were
the commonest complaint in the AVM subgroup whilst most cav-
ernoma were diagnosed incidentally.
Figure 2: Location of lobar AVM. 70.2% of AVMs were lobar
with the commonest areas affected being the frontal as can be
shown in Fig. 2. 23.4% of AVMs were deep and 6.4% were cerebel-
lar. AVMs in deep locations were located in the thalamo-capsular
region over the corpus callosum, brainstem, floor of the fourth
ventricle, basal ganglia, thalamus, the splenium of the corpus cal-
losum and the floor of the middle cranial fossa.
giogram). 51% of patients diagnosed with an AVM, had
a cerebral angiogram of which 87.5% took place prior to
therapeutic interventions, be it excision, radiosurgery
or embolization. 61.7% had follow-up imaging within a
year since diagnosis. 70.2% of AVMs were lobar with
the commonest areas affected being the frontal as can
be shown in Fig. 2. 23.4% of AVMs were deep and 6.4%
were cerebellar. Size was documented in 46.8% of cases
where an AVM was detected.
82.8% of cavernomas were diagnosed on MRI (includ-
ing MRA) with only 8.5% being diagnosed using a CT
(including CT Angiogram). 54% of the cavernoma were
lobar (as shown in Fig. 3), 43% were deep and 3%
were cerebellar. In 80% of cases, dimensions of the
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Table 1: Demographic data of patients participating in the study. The AVM and Cavernoma subgroups showing the number
of male and female participants. The mean age at the time of diagnosis based on the gender is shown.
AVM Mean age at diagnosis
of AVM
Cavernoma Mean age at diagnosis
of cavernoma
Male 29 44.89 12 56.42
Female 18 40.44 23 42.00
cavernoma/s were included in the radiological report.
65.7% of patients were followed-up with some form of
imaging modality within one year of the diagnosis.
Management of IVM is made on a case-by-case basis.
Fig. 4 shows a summary of the interventions offered to
patients diagnosed with an ICM.
Figure 3: Location of lobar cavernoma. 54% of the cav-
ernoma were lobar, 43% were deep and 3% were cerebellar. Deep
seated cavernoma were located in the centrum semiovale, pons,
lentiform nucleus, adjacent to the ventricles, basal ganglia, mid-
brain, thalamus, periventricular area, hippocampus and medulla.
The most common complication in both subgroups is
haemorrhage with 36.2% of patients with an AVM suf-
fering a bleed either at the time of presentation or during
the period of follow-up. In comparison, 37.1% of pa-
tients with a cavernoma had a bleed wither at presenta-
tion or thereafter. Seizures and progressive neurological
deficits were commoner in the AVM subgroup in com-
parison to the cavernoma subgroup, as can be seen in
Fig. 5. Interestingly, no statistically significant increase
in complications was noted between patients who were
regularly followed-up with imaging but never received
a therapeutic intervention and those who received some
form of intervention. A p-value of 0.09 was obtained
when comparing haemorrhage rates between the afore
mentioned sub-groups, a p-value of 0.48 when compar-
ing seizures and a p-value of 0.62 when comparing the
rates of progressing focal neurological signs.
Out of the 35 individuals who were diagnosed with a
cavernoma, 8.6% were diagnosed with multiple lesions
affecting both sides of the brain.
Figure 4: Management of ICM. 42.6% of patients with an
AVM had radiosurgery with the commonest modality used being
Gamma knife. Cyberknife and stereotactic radiosurgery where
other modalities used. This is in contrast to the cavernoma sub-
group where a minority of 8.5% were treated with Gamma knife
radiosurgery. A single patient was offered debulking surgery.
Figure 5: Complications of ICM. 36.2% of patients had haem-
orrhage as a complication of the AVM of which 82.4% had it at
presentation and 17.6% had multiple episodes. In 11.8% of cases
where haemorrhage was documented, the haemorrhage was the
cause of death. This is in contrast to cavernomas where 37% of
patients had haemorrhage with up to 75% of these having the
bleed at presentation.
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4 Discussion
4.1 Arteriovenous Malformations
Intracranial AVMs are a relatively rare occurrence and
are typically congenital vascular anomalies. They are
composed of complex connections between arteries and
veins without any intervening capillary bed. The veins
are typically tortuous and dilated secondary to the
high velocity of the blood flowing through the fistula.
Some conditions linked to intracranial AVMs include
Sturge-Weber disease, Osler-Weber-Rendu syndrome,
von Hippel-Lindau syndrome and neurofibromatosis (In-
ternational RadioSurgery Association, 2009). Mohr,
Kejda-Scharler and Pile-Spellman (2013) suggest an in-
cidence of AVMs of 0.1%, whereas that in the Maltese
population was found to be 0.01%.
Although the AVMs are typically congenital, patients
typically present in early adulthood between the ages of
20–40 (Fleetwood IG, 2002). Seizures or brain haem-
orrhage may occur in the younger and elder popula-
tion as an incident event. Up to 66% of adults who
have been found to have an AVM might also have a his-
tory of subtle learning disorder (International RadioSur-
gery Association, 2009). Presentation can be varied
with headaches, seizures, progressive neurological defi-
cit or brain haemorrhage being the commonest mode
of presentation. Indeed many AVMs are identified once
there is sudden onset of bleeding that can merely lead
to a headache with or without any neurological signs
or can be fatal. Deep seated AVMs are the most likely
to present with haemorrhage. Bleeding can occur into
the brain parenchyma, subarachnoid space or the intra-
ventricular space. Patients with an AVM carry an an-
nual risk of 1–4% of getting an intracranial bleed (Fleet-
wood IG, 2002) with particular angiographic features,
such as, small/deep venous drainage and high pressures
of the arterial and venous components of the AVM nidus
increasing the chance of bleeding further. Previous rup-
ture, as well as, young age are other predictors of in-
creased risk of bleeding. The risk of bleeding is highest
in the first 5 years after diagnosis yet it remains signi-
ficant for decades (Laakso et al., 2008).
Headaches are the commonest presentation of AVMs.
The headaches can be typical for migraines, especially
if the AVM is a subcortical lobar one, or can present
with non-specific generalised headache. Seizures can be
both focal or secondary generalised in nature. Progress-
ive neurological deficits may be a presenting feature if
the AVM is enlarging or if there is high pressure in the
draining vessels causing a mass effect. In the absence
of the mass effect, progressive neurological deficits can
occur secondary to the ‘steal phenomenon’, where blood
is syphoned away from the adjacent brain parenchyma
into the AVM nidus (International RadioSurgery Asso-
ciation, 2009).
High-resolution neurodiagnostic imaging is indicated
in patients presenting with any of the symptoms com-
mon to AVMs. Magnetic resonance imaging with cereb-
ral angiography is required to identify AVMs. Cerebral
angiography helps to assess the haemodynamics and the
morphology of the AVM, which are essential when plan-
ning treatment. Important features include the presence
of any arterial or venous aneurysms within the nidus of
the AVM, which increase the risk of rupture, the venous
draining patterns and the feeding vessels (International
RadioSurgery Association, 2009).
Management of the AVM depends on the nature of the
AVM, risk of subsequent bleeds and any co-morbidities.
There are four management strategies: observation, en-
dovascular embolization, stereotactic radiosurgery and
surgical excision. Observation may be ideal for patients
with large volume AVMs, especially if there has never
been an episode of bleeding. Endovascular embolization
is typically used as an adjunctive therapy prior to sur-
gery and can only be used if a part of the AVM nidus
can be obliterated successfully. Stereotactic radiosur-
gery is recognised for AVMs that cannot be resected.
Depending on the patients’ age, AVM location, size and
underlying comorbidities one can opt for Gamma knife
radiosurgery, linear accelerators or proton beam therapy
(International RadioSurgery Association, 2009).
4.2 Cerebral Cavernous Malformations
Cerebral cavernous malformations (CCMs) are a collec-
tion of atypical blood vessels through which blood flow is
sluggish. They are rarer than AVMs with an incidence
of 0.4–0.8% (Mouchtouris et al., 2014). In our study,
the incidence was of 0.008% which was significantly less
than that for AVMs and also lower than that in pub-
lished data.
CCMs carry a risk of haemorrhage as blood tends
to leak through the inter-cellular junctions making up
the walls of the cavernoma (Samarasekera et al., 2005).
Most cavernomas occur sporadically however, some have
been noted to be inherited in an autosomal dominant
pattern with mutations in the CCM1, CCM2 and CCM3
genes being linked to such inheritance. Studies have
shown that in adults with a single cavernous malforma-
tion but with no family history the chance of a mutation
is up to 1% whilst in adults who have at least one cav-
ernoma and a positive family history, the chance of a
mutation being present is between 78–94% (D’Angelo
et al., 2011; D. L. Verlaan, Laurent, Rouleau & Siegle,
2004; D. J. Verlaan et al., 2004). Hence, it is recommen-
ded that in patients with a cavernoma and a positive
family history, investigations are carried out to check
for mutations in CCM1 - 3 genes.
Cavernomas, like AVMs, can present with intracranial
bleeding, epileptic seizures and focal neurological signs.
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The annual risk of an intracerebral bleed in someone
who has been diagnosed with a cavernoma that has
never bled is between 0.4% and 0.6%. The percentage
increases to between 3.8% and 22.9% if the cavernoma
has already leaked (Al-Shahi, Berg, Morrison, Awad
& Angioma Alliance scientific advisory board, 2008).
The risk of a second bleed decreases over time (Flem-
ming, Link, Christianson & Brown, 2012). Patients who
present with a first seizure have a risk of 94% of devel-
oping epilepsy in the first five years from the time of
diagnosis (Samarasekera et al., 2005).
Diagnostic imaging using T1-weighted and T2-
weighted MRI together with haem-sensitive sequences
is recommended in order to diagnose cavernomas and
assess whether they are solitary or multiple. It is also
recommended that in patients who have a brain mass
accompanied by substantial amount of blood and vaso-
genic oedema an assessment for the presence of a CCM
is carried out. Decisions regard whether patients should
be followed up with imaging or whether to refer for ra-
diosurgery should be done on a case-by-case basis as
there are currently no guidelines (Samarasekera et al.,
2005).
5 Conclusion
IVMs can cause significant morbidity and mortality in
patients and hence, their detection and follow-up is es-
sential. Data from this study suggests that incidence in
Malta is comparable to that overseas and that patients
are managed in a similar fashion albeit decisions are
taken on a case-by-case basis. A limitation of the study
was that death certificates were not looked into and thus
any IVMs that might have caused sudden death were
missed.
Documentation of size is essential as well as details re-
garding the feeding and draining vessels and the location
of any malformation as these might affect the clinicians’
decision to offer therapeutic intervention and might af-
fect prognosis. While the studies performed in the area
indicate the potential dangers of these ICMs, there is a
lack of consensus among clinicians on how to proceed
once an ICM has been detected. This raises the need
for a guideline, which would help direct clinicians as to
when follow-up scans should be undertaken and at which
point interventions should be offered to their patients.
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